Prognosis of extended-spectrum-beta-lactamase-producing agents in emphysematous pyelonephritis-results from a large, multicenter series

Ivan Robles-Torres, Jose and Castellani, Daniele and Trujillo-Santamaria, Hegel and Teoh, Jeremy Yuen-Chun and Tanidir, Yiloren and Gadu Campos-Salcedo, Jose and Ivan Bravo-Castro, Edgar and Langer Wroclawski, Marcelo and Kumar, Santosh and Eduardo Sanchez-Nunez, Juan and Enrique Espinosa-Aznar, Jose and Ragoori, Deepak and Bin Hamri, Saeed and Ong, Teng Aik and Paul Tarot-Chocooj, Cecil and Shrestha, Anil and Lakmichi, Mohamed Amine and Cosentino-Bellote, Mateus and Gabriel Vazquez-Lavista, Luis and Kabre, Boukary and Tiong, Ho Yee and Salvador Gomez-Guerra, Lauro and Kutukoglu, Umut and Brunhara Alves-Barbosa, Joao Arthur and Jaspersen, Jorge and Acevedo, Christian and Virgen-Gutierrez, Francisco and Agrawal, Sumit and Octaviano Duarte-Santos, Hugo and Ann, Chai Chu and Yeoh, Wei Sien and Gauhar, Vineet (2022) Prognosis of extended-spectrum-beta-lactamase-producing agents in emphysematous pyelonephritis-results from a large, multicenter series. PATHOGENS, 11 (12). ISSN 2076-0817, DOI https://doi.org/10.3390/pathogens11121397.

Full text not available from this repository.
Official URL: https://doi.org/10.3390/pathogens11121397

Abstract

Background: Emphysematous pyelonephritis (EPN) is a necrotizing infection of the kidney and surrounding tissues with significant mortality. We aimed to assess the clinical factors and their influence on prognosis in patients being managed for EPN with and without ESBL-producing bacteria and to identify if those with EPN due to ESBL infections fared any different. Methods: A retrospective analysis was performed on patients with EPN diagnosis from 22 centers across 11 countries (between 2013 and 2020). Demographics, clinical presentation, biochemical parameters, radiological features, microbiological characteristics, and therapeutic management were assessed. Univariable and multivariable analyses were performed to determine the independent variables associated with ESBL pathogens. A comparison of ESBL and non-ESBL mortality was performed evaluating treatment modality. Results: A total of 570 patients were included. Median (IQR) age was 57 (47-65) years. Among urine cultures, the most common isolated pathogen was Escherichia coli (62.2%). ESBL-producing agents were present in 291/556 urine cultures (52.3%). In multivariable analysis, thrombocytopenia (OR 1.616 95% CI 1.081-2.413, p = 0.019), and Huang-Tseng type 4 (OR 1.948 95% CI 1.005-3.778, p= 0.048) were independent predictors of ESBL pathogens. Patients with Huang-Tseng Scale type 1 had 55% less chance of having ESBL-producing pathogens (OR 1.616 95% CI 1.081-2.413, p = 0.019). Early nephrectomy (OR 2.3, p = 0.029) and delayed nephrectomy (OR 2.4, p = 0.015) were associated with increased mortality in patients with ESBL infections. Conservative/minimally invasive management reported an inverse association with mortality (OR 0.314, p = 0.001). Conclusions: ESBL bacteria in EPN were not significantly associated with mortality in EPN. However, ESBL infections were associated with poor prognosis when patients underwent nephrectomy compared conservative/minimally invasive management.

Item Type: Article
Funders: UNSPECIFIED
Uncontrolled Keywords: emphysematous pyelonephritis; extended-spectrum beta-lactamases; prognosis; nephrectomy; minimally invasive procedures
Subjects: Q Science > QR Microbiology
R Medicine > R Medicine (General)
Divisions: Faculty of Medicine > Surgery Department
Depositing User: Ms Koh Ai Peng
Date Deposited: 01 Nov 2024 08:33
Last Modified: 01 Nov 2024 08:33
URI: http://eprints.um.edu.my/id/eprint/46130

Actions (login required)

View Item View Item